Some large-cap stocks including momentum names like Pandora are trading in bear market territory after falling off their 52-week highs.» Read More
Nu Skin shares plunged on concerns over an investigation by Chinese authorities' into its business practices in the country.
Some of Thursday's midday movers:
CNBC's Herb Greenberg weighs in on Nu Skin as officials in China say they will investigate the company on pyramid scheme allegations.
Nu Skin shares are getting shellacked after the People's Daily in China ran a report suggesting the company is running an illegal pyramid scheme.
CNBC's Herb Greenberg reports on a controversy involving Nu Skin's China operations. Greenberg also shares his take on Valeant Pharma.
Some of Wednesday's midday movers:
Some of Tuesday's midday movers:
Some of Friday's midday movers.
Nu Skin soared on earnings data, and RadioShack hired 2 former JC Penney executives. CNBC's Herb Greenberg questions whether this will pay off for RadioShack.
Some of the names on the move ahead of the open.
It’s time for the Lightning Round. Cramer makes the call on viewer favorites.
Take a look at some of Thursday's midday movers:
The trouble, according to Joe Mariano, president of the Direct Selling Association, that "there are a lot of pyramid schemes that like to disguise themselves as legitimate direct-selling companies."
Multi-level marketers get a pass from regulators, critics say. Are consumers on the losing end?
The story of the guy who started it all.
The multi-level marketing sales pitch may not be for everyone. Former distributors speak up.
Multi-level marketing is a big business, but one critic says it's also a big lie.
Oct 31- Nu Skin Enterprises Inc raised its full-year forecast for the sixth time this year, encouraged by strong demand for its new anti-ageing and body spa products under the ageLOC brand. Nu Skin shares rose 11 percent to $46.70 on the New York Stock Exchange on Wednesday morning.
Oct 31- Nu Skin Enterprises Inc's quarterly results handily beat Wall Street expectations on strong performance of its anti-ageing and nutritional supplement businesses in China, prompting the company to raise its full-year forecast for the sixth time.
--Abiomed Inc rescheduled second-quarter conference call to Nov. 1 at 8 am Eastern Time. --Accelrys Inc rescheduled third-quarter results to Oct. 31, after market. Its conference call will be held on Nov. 1, 9.30 am Eastern Time.